Streetbeat News

Revenues

PYCR

Paycor HCM (NASDAQ:PYCR) reported Q4 2024 adjusted EPS of $0.11, beating the $0.09 estimate. Sales were $164.8M, surpassing the $161.172M estimate and marking a 17.68% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:17 pm

AISP

Airship AI Holdings (NASDAQ:AISP) reported a significant improvement in its Q2 earnings, with EPS rising to $0.58 from a loss of $(0.14) YoY, and sales increasing to $5.36M from $1.81M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:17 pm

AMS

American Shared Hospital (AMEX:AMS) reported Q2 earnings of $0.02 per share, missing the analyst estimate of $0.07. However, sales of $7.06 million beat the $6.15 million estimate.

Portfolio Pulse from totan@benzinga.com

August 14, 2024 | 8:17 pm

NVGS

Navigator Holdings (NYSE:NVGS) reported Q2 earnings per share of $0.34, beating the analyst estimate of $0.33. Sales were $146.68 million, surpassing the $133.49 million estimate. This represents a 36% increase in EPS and an 8.38% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:15 pm

UMAC

Unusual Machines (AMEX:UMAC) reported a Q2 EPS of $(0.16), a 23.08% decrease from $(0.13) YoY, with $1.41M in sales.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:14 pm

SHFS

SHF Holdings (NASDAQ: SHFS) reported Q2 GAAP EPS of $0.02, a significant improvement from $(0.40) YoY. However, sales decreased by 11.70% to $4.04M from $4.57M YoY.

Portfolio Pulse from saritha@benzinga.com

August 14, 2024 | 8:14 pm

RSLS

Reshape Lifesciences (NASDAQ:RSLS) reported Q2 EPS of $(0.06), a significant improvement from $(1.08) YoY, but missed sales estimates with $1.97M, down 12.82% YoY.

Portfolio Pulse from saritha@benzinga.com

August 14, 2024 | 8:11 pm

STNE

StoneCo reported Q2 2024 revenue of R$3.205 billion.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:11 pm

SNAX

Stryve Foods (NASDAQ:SNAX) reported Q2 2024 adjusted EPS of $(0.83), beating the analyst estimate of $(1.39) by 40.29%. The company also reported sales of $6.20 million, surpassing the $5.01 million estimate by 23.80%. This represents a 3.39% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:11 pm

SSKN

Strata Skin Sciences (NASDAQ:SSKN) reported Q2 sales of $8.40 million, surpassing the analyst consensus estimate of $7.42 million by 13.15%. This marks a 1.82% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:10 pm